The BPC-157/TB-500 blend combines two of the most studied research peptides — BPC-157, a synthetic pentadecapeptide derived from gastric juice, and TB-500, a synthetic fragment of Thymosin Beta-4 — into a single pre-measured vial. Researchers use blended vials like this to simplify combined-pathway study protocols instead of reconstituting and dosing two separate compounds. Helix Bio's blend is manufactured for laboratory use, supplied as a lyophilized powder with a clearly labeled mg-per-compound ratio, and backed by a certificate of analysis for every batch. It's intended strictly for qualified researchers and laboratories — not for human or animal use.
HPLC certified
Independent analysis
Highest standard
Full traceability
BPC-157 and TB-500 are frequently studied together in tissue-repair and recovery-focused research literature, since they're associated with overlapping but distinct pathways — BPC-157 with gastrointestinal protection and angiogenesis, TB-500 with actin-binding activity and cell migration research. A pre-blended vial exists for research convenience: instead of managing two separate reconstitution schedules and dosing calculations, a researcher works from a single vial with a fixed, labeled ratio.
Helix Bio supplies this blend strictly as a research compound. It is not formulated, labeled, or sold as a drug, supplement, or finished pharmaceutical product, and no therapeutic claims are made about it or its components.
Each vial contains a lyophilized blend of BPC-157 and TB-500 in a labeled mg-per-compound ratio, manufactured under controlled laboratory conditions and verified through HPLC (high-performance liquid chromatography) testing. The exact ratio and total peptide content per vial are documented on the certificate of analysis and product listing.
This product exists to support in vitro and in vivo laboratory research examining combined-pathway effects — for example, studies comparing a blended protocol against single-compound protocols in tissue-repair or recovery research models. It's built for researchers who need a documented, ratio-labeled compound source — not for personal or consumer use.
Blended peptide vials introduce a problem standalone compounds don't have: if the vendor isn't transparent about the ratio, a researcher has no reliable way to know how much of each compound they're actually working with. Helix Bio addresses that by labeling the mg-per-compound ratio clearly on the product listing and the COA, not just a vague "blend" designation. Every batch ships with third-party-verifiable documentation, cold-chain handling protects compound integrity in transit, and the RUO disclaimer stays consistent with every other product on the site. For labs that need to document exactly what went into a protocol, that ratio transparency is the difference-maker.
This product is not intended for personal use, human consumption, or administration of any kind outside a controlled research setting.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
